GRDN

Guardian Pharmacy Services, Inc.
GRDN
Market cap $1.32B

20.93 USD

-0.07

0.33%

At close Nov 15, 4:00 PM EST

1 day

-0.33%

5 days

-3.68%

1 month

22.40%

3 months

30.81%

6 months

30.81%

Year to date

30.81%

1 year

30.81%

5 years

30.81%

10 years

30.81%

About: Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.

Consumer Discretionary Drug Stores & Proprietary Stores

0

Funds holding %

of 6,704 funds

0

Analysts bullish %

of 3 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

105.1% more ownership

Funds ownership: 0% [Q2] → 105.1% (+105.1%) [Q3]

See Fund Rankings

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$21

0%

upside

Avg. target

$22

7%

upside

High target

$24

15%

upside

3 analyst ratings

3 positive

100%

0 neutral

0%

0 negative

0%

Truist Securities David Macdonald 67% 1-year accuracy 32 / 48 met price target	15%upside $24	Buy Maintained	15 Nov 2024
Stephens & Co. Scott Fidel 67% 1-year accuracy 22 / 33 met price target	0%upside $21	Overweight Initiated	22 Oct 2024
Truist Securities David Macdonald 67% 1-year accuracy 32 / 48 met price target	5%upside $22	Buy Initiated	21 Oct 2024

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about GRDN published over the past 30 days

Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Three Months Ended September 30, 2024 Revenue of $314.4 million, an increase of 20% year-over-year, driven by organic growth of the business and the previously announced acquisition of Heartland Pharmacy completed on April.

Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results

Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Stephens Annual Investment Conference, being held in Nashville, on Thursday, November 21, 2024, including a fireside chat at 9:00am CT. The live audio webcast of the fireside chat will be available online at https://investors.guardianpharmacy.com. A replay of the fireside chat will also be availab.

Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference

Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245.

Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating

Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc GRDN, which operates long-term care pharmacies that facilitate the full lifecycle of pharmacy administration and associated consultative services for residents of long-term healthcare facilities (LTCFs).

Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Four IPOs and two SPACs submitted initial filings this past week. Six IPOs are currently scheduled to list in the week ahead.

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million.

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday.

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the pricing of its upsized initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $14.00 per share. In addition, Guardian has granted the underwriters a 30-day option to purchase up to 1,200,000 additional shares of Class A common stock at the public offering price, less the underwriting discount. The shares are expected to begin trading on the New York Stock Exchan.

Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering

U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost

Two small IPOs and two SPACs debuted this past week - Global Engine, Kairos Pharma, YHN Acquisition I, and Cayson Acquisition, respectively. Seven IPOs and three SPACs submitted initial filings. Eight companies are expected to price their IPOs in the upcoming week, including three larger deals.

U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost

See News Rankings

Charts implemented using Lightweight Charts™